SE-EA extract and its active compounds, EGF-A and EGF-B can effectively suppress the invasion of A549 lung cancer cells stimulated by LPS-ATP via the NLRP3 inflammasome pathway. The gene discussed is NLRP3; the disease is lung cancer.